Pimblett Emily
SVP, Finance & CAO at CLYM
- Sold, on record
- $24k
- Dollars the filings state
- Form 4 sales
- 5
- Latest Jun 20, 2025
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- CLYMClimb Bio, Inc.SVP, Finance & CAO
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale CLYMNo planJun 20, 2024 2024
Sold 1,245 shares at $7.21 ($9k)
Pimblett Emily, CHIEF ACCOUNTING OFFICER
No 10b5-1 planSold 24.9% of holdings ($36k position)3,755 shares leftFirst sale on recordFiling
- 2 Form 4 sale CLYMRoutineSep 20, 2024 +92 days
Sold 1,191 shares at $8.18 ($10k)
Pimblett Emily, CHIEF ACCOUNTING OFFICER
10b5-1 planSold 13.6% of holdings ($72k position)7,564 shares leftFiling
- 3 Form 4 sale CLYMRoutineDec 19, 2024 +90 days
Sold 1,235 shares at $2.02 ($2k)
Pimblett Emily, CHIEF ACCOUNTING OFFICER
10b5-1 planSold 9.8% of holdings ($25k position)11,329 shares leftFiling
- 4 Form 4 sale CLYMRoutineMar 20, 2025 +91 days
Sold 1,199 shares at $1.31 ($2k)
Pimblett Emily, SVP, Finance & CAO
10b5-1 planSold 7.3% of holdings ($21k position)15,130 shares left1x usual sizeFiling
- 5 Form 4 sale CLYMRoutineJun 20, 2025 +92 days
Sold 1,242 shares at $1.24 ($2k)
Pimblett Emily, SVP, Finance & CAO
10b5-1 planSold 6.2% of holdings ($25k position)18,888 shares left1x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (5)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jun 20, 2025 | Jun 20, 2025 | CLYM | SVP, Finance & CAO | Form 4 sale | 1,242 | $2k | 6.2% | Routine | SEC |
| Mar 20, 2025 | Mar 20, 2025 | CLYM | SVP, Finance & CAO | Form 4 sale | 1,199 | $2k | 7.3% | Routine | SEC |
| Dec 19, 2024 | Dec 20, 2024 | CLYM | CHIEF ACCOUNTING OFFICER | Form 4 sale | 1,235 | $2k | 9.8% | Routine | SEC |
| Sep 20, 2024 | Sep 20, 2024 | CLYM | CHIEF ACCOUNTING OFFICER | Form 4 sale | 1,191 | $10k | 13.6% | Routine | SEC |
| Jun 20, 2024 | Jun 21, 2024 | CLYM | CHIEF ACCOUNTING OFFICER | Form 4 sale | 1,245 | $9k | 24.9% | No plan | SEC |